Generation Bio Co reports results for the quarter ended in March - Earnings Summary

Generation Bio

10/05/2023 23:34

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted
loss
of 53 cents​​ per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for a loss
of 46 cents per share.
    * Reported revenue was zero​; analysts expected $7.92
million. 
    * Generation Bio Co's reported EPS for the quarter was a
loss
of 53 cents​.
    * The mean earnings estimate of analysts had risen by
about 17.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Generation Bio Co shares had risen by 12.1% this
quarter and
gained 22.6% so far this year.
    * The company reported a quarterly loss of $32.09 million.
    * Wall Street's median 12-month price target for Generation
Bio Co
is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 10:34 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.46          -0.53          Missed
 Dec. 31 2022      -0.58          -0.55          Beat
 Sep. 30 2022      -0.67          -0.53          Beat
 Jun. 30 2022      -0.62          -0.66          Missed